文献速递鼻科

内镜鼻窦手术后五年EuroQol五维量表结局

Five-year EuroQol 5-Dimension Outcomes After Endoscopic Sinus Surgery.
PubMed 文献 · Laryngoscope · 2023-12-21

前瞻性观察性队列研究纳入1296例慢性鼻窦炎患者,术前及内镜鼻窦术后每年完成EQ-5D问卷至五年。疼痛/不适和焦虑/抑郁报告率显著持续下降至五年,日常活动问题频率在术后一年下降并持续至第四年;女性、既往鼻窦手术、吸烟、头痛、过敏、糖尿病、高血压、较高术前SNOT-22评分和较低术前Lund-Mackay评分与较差的EQ-5D健康效用值相关。

要点

  • 疼痛/不适报告率从术前74.9%降至五年58.0%,焦虑/抑郁从49.6%降至38.1%,均显著。
  • 日常活动问题频率术后一年下降并持续至第四年(30.6% vs 19.7%)。
  • 女性、既往鼻窦手术、吸烟、头痛、过敏、糖尿病、高血压等与较差EQ-5D健康效用值相关。

核心结论

  • 慢性鼻窦炎患者在内镜鼻窦手术后五年内,EQ-5D测量的健康相关生活质量出现显著且持续的改善。

研究设计与样本

  • 前瞻性观察性队列研究,纳入1296例接受内镜鼻窦手术的慢性鼻窦炎患者,术前及术后每年完成EQ-5D问卷至五年。

主要发现

  • 疼痛/不适报告率术前74.9% vs 术后五年58.0%(p < 0.001),焦虑/抑郁报告率术前49.6% vs 术后五年38.1%(p = 0.01),均显著持续下降。
  • 日常活动问题频率术后一年下降并持续至第四年(30.6% vs 19.7%,p = 0.003)。
  • 多变量模型显示女性(p = 0.02)、既往鼻窦手术(p = 0.01)、吸烟(p = 0.038)、头痛(p = 0.013)、过敏(p = 0.001)、糖尿病(p = 0.022)、高血压(p = 0.036)、较高术前SNOT-22评分(p < 0.001)和较低术前Lund-Mackay评分(p < 0.001)与较差的EQ-5D健康效用值随时间相关。
  • 较差的EQ-5D视觉模拟量表随时间与过敏(p = 0.03)、糖尿病(p < 0.001)、高血压(p = 0.04)、较高术前SNOT-22评分(p < 0.001)和既往鼻窦手术(p < 0.001)相关。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: The EuroQol 5-Dimension (EQ-5D) is a general health survey that is quick to administer, widely used, and directly convertible to health utility values (HUV). We aim to describe the five-year EQ-5D outcomes among patients who undergo surgical treatment for chronic rhinosinusitis (CRS). STUDY DESIGN: Prospective observational cohort study. METHODS: Patients with CRS completed the EQ-5D questionnaire preoperatively and annually for five years following endoscopic sinus surgery. Paired t-tests and McNemar's tests were used to compare preoperative and postoperative scores. Mixed-effects modeling was used for multivariate analysis. RESULTS: Among 1296 patients enrolled in our study, 812 (74.7%) completed the postoperative survey at one year and 336 (38.9%) completed it at five years. There was a significant and sustained reduction of patients reporting pain/discomfort (74.9% vs. 58.0%, p < 0.001) and anxiety/depression (49.6% vs. 38.1%, p = 0.01) out to five years. Frequency of problems reported in the usual activity domain decreased at one year and was sustained through year four (30.6% vs 19.7%, p = 0.003). After multivariable modeling, female gender (p = 0.02), prior sinus surgery (p = 0.01), tobacco use (p = 0.038), headaches (p = 0.013), allergies (p = 0.001), diabetes (p = 0.022), hypertension (p = 0.036), higher preoperative SNOT-22 score (p < 0.001), and a lower preoperative Lund-Mackay score (p < 0.001) were associated with significantly worse EQ-5D HUV over time. Similarly, a worse EQ-5D Visual Analog Scale (VAS) over time was associated with allergies (p = 0.03), diabetes (p < 0.001), hypertension (p = 0.04), higher preoperative SNOT-22 score (p < 0.001), and prior sinus surgery (p < 0.001). CONCLUSION: Patients with chronic rhinosinusitis experience significant sustained improvements in health-related quality of life up to five years after ESS as measured by the EQ-5D instrument. LEVEL OF EVIDENCE: Level 2 Laryngoscope, 134:2592-2601, 2024.

来源:Laryngoscope,查看原文。版权归原作者所有。

引用

  1. Tashman K, Adams D, Vickery TW, et al. Five-year EuroQol 5-Dimension Outcomes After Endoscopic Sinus Surgery. Laryngoscope. 2023. PMID: 38126531. doi:10.1002/lary.31206

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。